PulmCCM

Home
Index
Reviews
Physiology
All
Book
About

Hemorrhage and Hematology

More data on Impella complications emerge
Six months later, DanGer-Shock post hocs add detail on AKI and bleeding
 • 
PulmCCM
Blood transfusion targets in acute brain injury: Review
Are brain injuries an exception to the "less is more" heuristic in transfusion during critical illness?
 • 
PulmCCM
2
Albumin as resuscitation fluid for septic shock: Review
ABC-SEPSIS trial adds to aging body of evidence
 • 
PulmCCM
6
Tranexamic acid for GI bleeds: Review
Going retro can be a gas, but not in randomized trials
 • 
PulmCCM
2
Tranexamic acid for prevention of surgical bleeding: Review
The benefits are (mostly) clear. What are the risks?
 • 
PulmCCM
Tranexamic acid no help during hepatic resection
Patients had same transfusion rate + more complications with TXA
 • 
PulmCCM
Do thrombolytics improve outcomes in less severe strokes?
TEMPO-2, testing TNK vs antiplatelets, may have decided things
 • 
PulmCCM
FDA approves Balfaxar, a Kcentra competitor for coagulopathy reversal
With postmarketing studies on the drug's safety profile to follow
 • 
PulmCCM
2
Do PPIs for stress ulcer prophylaxis cause death in the sickest patients?
2024 meta-analysis revives concerns about PPIs' risks
 • 
PulmCCM
3
Reteplase vs alteplase for ischemic stroke
RAISE trial tests the compound against tPA in China
 • 
PulmCCM
Stress ulcer prophylaxis in the ICU: Review
2024 REVISE trial adds data on benefits, though theoretical risk of harm persists
 • 
PulmCCM
For undifferentiated strokes, should blood pressure be reduced pre-hospital?
The INTERACT-4 trial may have finally put the question to rest
 • 
PulmCCM
© 2024 PulmCCM LLC
Substack
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture